The burgeoning landscape of treatment for obesity and type 2 diabetes is currently witnessing considerable interest surrounding both retatrutide and tirzepatide. While both represent novel dual GIP and GLP-1 binding https://jayawtzz852886.tokka-blog.com/39272524/retatrutide-vs-tirzepatide-a-comparative-analysis